2D and 3D in-vitro models for mimicking cardiac physiology
journal contributionposted on 2022-09-15, 16:19 authored by Gerges Abdelsayed, Danish Ali, Andrew Malone, Jemil Saidi, Manoj Myneni, Keshava Rajagopal, Faisal H Cheema, Aamir HameedAamir Hameed
Cardiovascular diseases are the leading cause of morbidity and mortality and a huge economic burden on the healthcare system globally. Both pharmacological and device based treatment options have emerged over the years, however, it is still a ‘holy grail’ to effectively treat some cardiovascular conditions, for example, heart failure. Any treatment option whether it is drug therapy or a device therapy, has to go through a rigorous regulatory approval process. This requires robust pre-clinical research and clinical trial results. In order to proceed to the clinical trials, pre-clinical research is very important and may take methodologies which are at the interface of biology and engineering, for example, in-vitro, ex-vivo and in-vivo models. This paper focusses on the 2D and 3D in-vitro models to mimic the pathophysiology of a specific cardiovascular disease and their advantages and limitations.
CommentsThe original article is available at https://www.sciencedirect.com/
Published CitationAbdelsayed G, et al. 2D and 3D in-vitro models for mimicking cardiac physiology. Applications in Engineering Science. 2022;12:100115.
Publication Date28 August 2022
- Anatomy and Regenerative Medicine
- Tissue Engineering Research Group (TERG)
- Undergraduate Research
- Biomaterials and Regenerative Medicine
- Health Professions Education
- Surgical Science and Practice
- Published Version (Version of Record)